Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease

Robert Howard(University College London), Patrick Phillips(Unknown), Martín Knapp(London School of Economics and Political Science), Caroline Onions(University of Oxford), Cornelius Katona(University College London), John T. O’Brien(North Tyneside General Hospital), Robin Jacoby(University of Oxford), Robert Barber(University of North Texas), Alistair Burns(University of Manchester), Clive Ballard(University of Exeter), Craig Ritchie(Western General Hospital), Sube Banerjee(University of Nottingham), James Lindesay(University of Leicester), Rupert McShane(Oxford Health NHS Foundation Trust), Tom Dening(University of Nottingham), Bart Sheehan(University of Warwick), Robert K. Hills(Cancer Research UK Clinical Trials Unit), Roy Jones(Royal United Hospital), Richard G. Brown(Imperial College London), Edmund Juszczak, Peter Bentham(Queen Elizabeth Hospital Birmingham), Mary Griffin(Avon and Wiltshire Mental Health Partnership NHS Trust), Peter Passmore(Queen's University Belfast), Ashley Baldwin(Whiston Hospital), Clive Holmes(University of Eastern Finland), David M. Findlay(The University of Adelaide), Ajay Macharouthu(Crichton Royal Hospital), Richard Gray(Barnsley Hospital NHS Foundation Trust), Tony Johnson(University of Liverpool), Jessica Adams, Ian G. McKeith(Newcastle Hospitals - Campus for Ageing and Vitality), Alan Hughes(Inverclyde Royal Hospital), Rob Jones(University of Nottingham)
New England Journal of Medicine
March 7, 2012
Cited by 774


Related Papers